STAT3 in Prostate Cancer: Whom Should We Treat and When?

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Urology

• Publication date

  2017-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.eururo.2016.06.034PMID 27402062
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of STAT3 in Prostate Cancer Metastases.

  2017cited by this paper
• EC-70124, a Novel Glycosylated Indolocarbazole Multikinase Inhibitor, Reverts Tumorigenic and Stem Cell Properties in Prostate Cancer by Inhibiting STAT3 and NF-κB

  2016cited by this paper
• IL-6 Overexpression in ERG-Positive Prostate Cancer Is Mediated by Prostaglandin Receptor EP2.

  2016cited by this paper
• STAT3 regulated ARF expression suppresses prostate cancer metastasis

  2015cited by this paper
• TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells

  2015cited by this paper
• JAK-STAT blockade inhibits tumor initiation and clonogenic recovery of prostate cancer stem-like cells.

  2013cited by this paper
• Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer

  2010cited by this paper
• Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice.

  2006cited by this paper
• Regulation of growth of prostate cancer cells selected in the presence of interleukin‐6 by the anti‐interleukin‐6 antibody CNTO 328

  2006cited by this paper
• Interleukin‐6 inhibits the growth of prostate cancer xenografts in mice by the process of neuroendocrine differentiation

  2004influential reference
• Regulation of growth of fibroblasts.

  1978cited by this paper

• The role of IL-22 in cancer

  2024cites this paper
• Identification of marine natural product Pretrichodermamide B as a STAT3 inhibitor for efficient anticancer therapy

  2023cites this paper
• HSPB8 facilitates prostate cancer progression via activating JAK/STAT3 signaling pathway.

  2022cites this paper
• Synthesis of KUE‐siRNA Conjugates for Prostate Cancer Cell‐Targeted Gene Silencing

  2021cites this paper
• Cáncer de próstata de inicio temprano. ¿Una nueva entidad?

  2021cites this paper
• Long noncoding RNA DANCR promotes nasopharyngeal carcinoma progression by interacting with STAT3, enhancing IL-6/JAK1/STAT3 signaling.

  2019cites this paper
• Artesunate enhances γδ T-cell-mediated antitumor activity through augmenting γδ T-cell function and reversing immune escape of HepG2 cells

  2018cites this paper
• Interleukin-30/IL27p28 Shapes Prostate Cancer Stem-like Cell Behavior and Is Critical for Tumor Onset and Metastasization.

  2018cites this paper
• MicroRNA and Transcription Factor Gene Regulatory Network Analysis Reveals Key Regulatory Elements Associated with Prostate Cancer Progression

  2016cites this paper